These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 32221746)

  • 21. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
    Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
    Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
    Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
    Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
    Shi YX; Zhu T; Zou T; Zhuo W; Chen YX; Huang MS; Zheng W; Wang CJ; Li X; Mao XY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Dec; 7(51):85235-85243. PubMed ID: 27835911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
    Pan S; Zhan Y; Chen X; Wu B; Liu B
    Front Oncol; 2019; 9():613. PubMed ID: 31334127
    [No Abstract]   [Full Text] [Related]  

  • 26. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases.
    Liu W; Ouyang S; Zhou Z; Wang M; Wang T; Qi Y; Zhao C; Chen K; Dai L
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00528. PubMed ID: 30556321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.
    Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B
    BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma.
    Guo L; Li H; Li W; Tang J
    BMC Med Genomics; 2020 Nov; 13(1):166. PubMed ID: 33148251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
    Wang XC; Liu Y; Long FW; Liu LR; Fan CW
    Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma.
    Shi H; Han L; Zhao J; Wang K; Xu M; Shi J; Dong Z
    Cancer Med; 2021 Dec; 10(24):8944-8960. PubMed ID: 34741449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.
    Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C
    Front Genet; 2022; 13():860268. PubMed ID: 35464867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the Lung Adenocarcinoma Stem Cell Biomarker Expressions Using Machine Learning Approaches.
    Bhuvaneswari MS; Priyadharsini S; Balaganesh N; Theenathayalan R; Hailu TA
    Biomed Res Int; 2022; 2022():3518190. PubMed ID: 36193299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
    Xia P; Li Q; Wu G; Huang Y
    J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
    Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
    Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.